BYSI Stock Analysis: Buy, Sell, or Hold?
BYSI - BeyondSpring Inc. Ordinary Shares
$1.73
0.02 (0.88%)
▲
5d:
+7.14%
30d:
+12.01%
90d:
+5.83%
WAIT
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 11, 2026
Get Alerted When BYSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BYSI shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BYSI shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BYSI is currently trading at $1.73, which is considered extended relative to its 30-day fair value range of $1.44 to $1.71.
Technical Outlook: Technically, BYSI is in a strong downtrend. The price is approaching resistance at $1.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $1.25. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BYSI is in a strong downtrend. The price is approaching resistance at $1.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $1.25. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.44 -
$1.71
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 27.5% above Wall St target ($1.25)
Fair Price Analysis
30-Day Fair Range
$1.44 -
$1.71
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.52
Resistance Level
$1.75
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.54
Wall Street Target
$1.25
(-27.5%)
Revenue Growth (YoY)
14.3%
Share & Embed Analysis
Last updated: April 05, 2026 6:31 PM ET
Data refreshes hourly during market hours. Next update: 7:31 PM
Data refreshes hourly during market hours. Next update: 7:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BYSI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 58 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 50 HOLD |